Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medclair is a Swedish medical technology company specializing in the collection and destruction of nitrous oxide (N2O), a potent greenhouse gas used extensively in healthcare for pain relief. The company provides a range of solutions, including mobile and central destruction units, as well as gas monitoring systems, to help hospitals reduce their carbon footprint and improve the working environment for staff. Their proprietary catalytic technology converts nitrous oxide into harmless nitrogen and oxygen with an efficiency rate exceeding 99%. Medclair's products are currently deployed in several European markets, with a significant presence in the UK's NHS, and are expanding globally to meet increasing environmental regulations. By addressing the climate impact of anesthetic gases, Medclair enables healthcare providers to maintain high standards of patient care while achieving sustainability goals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medclair.